At a Glance
News & Publications
Preclinical assessment of the Absorption, Distribution, Metabolism and Excretion of HMPL-013, a novel potent and specific VEGFR inhibitor (ISSX 2011)
Volitinib (HMPL-504) against subcutaneous xenograft and orthotopic brain tumor models (AACR 2011)
Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis – a double-blind comparison with sustained release mesalazine (Alimentary Pharmacology and Therapeutics 2011)
Preclinical assessment of the absorption, distribution, metabolism and excretion of HMPL-013, a novel potent and specific VEGFR inhibitor (ISSX 2011)
Copyright ©2018 Hutchison MediPharma Limited. All rights reserved.